The present invention is directed toward devices, systems, and methods for performing a heart procedure.
Blood returning to the heart from peripheral circulation and the lungs generally flows into the atrial chambers of the heart and then to the ventricular chambers, which pump the blood back out of the heart. During ventricular contraction, the atrio-ventricular valves between the atria and ventricles (i.e. the tricuspid and mitral valves), close to prevent backflow or regurgitation of blood from the ventricles back to the atria. The closure of these valves, along with the aortic and pulmonary valves, maintains the unidirectional flow of blood through the cardiovascular system. Disease of the valves can result in valve dysfunction, where some fraction of the ventricular blood regurgitates back into the atrial chambers.
Treatment of heart valve stenosis or regurgitation, such as mitral or tricuspid regurgitation, may involve an open-heart surgical procedure to replace or repair the valve. Methods and devices have been developed to accomplish ventriculoplasty on the left ventricle of the human heart for patients suffering from functional mitral valve regurgitation and/or congestive heart failure. A device such as a delivery catheter may be advanced into the heart to place a set of anchors within the left ventricular myocardium in a subannular region between the mitral annulus and the papillary muscles. The anchors are coupled together by a tether. Once the anchors and tether are released, the tether is cinched in order to reduce the mitral annulus, creating mitral valve competence and relieving left ventricle wall stress. Additional devices and methods for releasing anchor structures from a catheter may be desirable.
Described here are devices, systems, and methods for removing a catheter from a body organ. In general, the systems described here for delivering an implant comprise a catheter comprising a longitudinal axis, a first elongate element lumen, a second elongate element lumen, a tissue anchor lumen, and a plurality of apertures along the longitudinal axis. The plurality of apertures may comprise first elongate element apertures, second elongate element apertures, and tissue anchor apertures. The catheter may further comprise a plurality of retaining portions each between adjacent tissue anchor apertures and between adjacent first and second elongate element apertures. A first elongate element may be disposed within the first elongate element lumen. A second elongate element may be disposed within the second elongate element lumen. For each pair of adjacent first and second elongate element apertures, the first elongate element may extend out of the first elongate element lumen through the first elongate element aperture across the retaining portion transversely with respect to the longitudinal axis and towards the second elongate element aperture. The first elongate element may extend into the second elongate element aperture, loop over the second elongate element, and extend back across the retaining portion and into the first elongate element lumen.
In some variations, the first elongate element may be releasably coupled to the second elongate element. In other variations, the first elongate element extending between the first and second elongate element apertures may cross over itself. In yet other variations, the first elongate element may be fixed to a distal end of the catheter.
In some variations, a first elongate element control may be configured to retract the first elongate element from the first elongate element lumen and a second elongate element control may be configured to retract the second elongate element from the second elongate element lumen. In some of these variations, retracting the first elongate element from the first elongate element lumen may tension the first elongate element.
In some variations, the plurality of retaining portions may each comprise a channel along the longitudinal axis. In some of these variations, the plurality of retaining portions may be each adapted to open the channel.
In yet further variations, at least one radiopaque structure may be located between the plurality of apertures.
In some variations, an anchor delivery catheter may be advanceable within the catheter and a plurality of tissue anchors within the anchor delivery catheter. In some of these variations, the tissue anchor apertures may be configured for passage of the plurality of tissue anchors. In another of these variations, the anchor delivery catheter may be advanceable within the tissue anchor lumen.
Also described here are methods for performing a procedure inside a heart. In general, the methods comprise positioning a catheter adjacent to heart tissue. The catheter may comprise a longitudinal axis, a first elongate element lumen, a second elongate element lumen, a tissue anchor lumen, and a plurality of apertures along the longitudinal axis. The plurality of apertures may comprise first elongate element apertures, second elongate element apertures, and tissue anchor apertures. The catheter may further comprise a plurality of retaining portions each between adjacent tissue anchor apertures and between adjacent first and second elongate element apertures. A first elongate element may be disposed within the first elongate element lumen and a second elongate element may be disposed within the second elongate element lumen. The plurality of retaining portions may each comprise a channel along the longitudinal axis. For each pair of adjacent first and second elongate element apertures, the first elongate element may extend out of the first elongate element lumen through the first elongate element aperture across the retaining portion transversely with respect to the longitudinal axis and towards the second elongate element aperture. The first elongate element may extend into the second elongate element aperture, loop over the second elongate element, and extend back across the retaining portion and into the first elongate element lumen. A first tissue anchor and at least a second tissue anchor may be deployed into the heart tissue. A tether may couple the first tissue anchor to at least the second tissue anchor. The second elongate element may be retracted from the second elongate element lumen to uncouple the first elongate element from the second elongate element and to open the channel for passage of the first and second tissue anchors. The uncoupled first elongate element may be tensioned. The catheter may be removed from the heart.
In some variations, the catheter may be temporarily secured to heart tissue using at least one of the first and second tissue anchor. In other variations, retracting the second elongate element may increase slack of the first elongate element. In yet other variations, retracting the second elongate element may open the channel. In some variations, the first elongate element may cross over itself. In other variations, the first elongate element may be tensioned against the second elongate element. In yet other variations, the catheter may be indirectly visualized. In some variations, an anchor delivery catheter may be advanced within the catheter.
Described here are devices, systems, and methods for detaching or decoupling an outer catheter from an implanted device during a heart procedure, such as from a subannular region of the left ventricle. Generally, the devices and systems described here are used to reshape atrio-ventricular valves or myocardium to improve hemodynamic performance. The implantation procedures are preferably transvascular, minimally invasive surgical procedures, but can also be performed with open or limited access surgical procedures.
In instances where the heart is the relevant anatomy, it may be helpful to briefly identify and describe the relevant heart anatomy.
Catheter 100 is generally a flexible elongate catheter which may have one or more curves or bends towards its distal end to facilitate placement of the distal end 102 of the catheter 100 at a desired location. The subvalvular space, as used herein, generally includes the portion of the ventricular chamber that is bound peripherally by the ventricular wall, superiorly by the atrio-ventricular valve leaflets, and centrally by the primary chordae tendineae, and is located along the circumference of the valve annulus. The subannular groove region 104, as used herein, includes the space bordered by the inner surface of the ventricular wall, the inferior surface of valve leaflets MVL, and the third order chordae tendineae connected directly to the ventricular wall and the leaflet MVL.
The distal end 102 of catheter 100 may be configured to be positioned at an opening into the subvalvular space 106 or within the subvalvular space 106, such that subsequent devices may be passed through catheter 100 into the subvalvular space 106. Although the retrograde aortic access route may begin from a percutaneous or peripheral access site, aortic access may alternatively be achieved by an incision in the ascending aorta, descending aorta, aortic arch or iliac arteries, following surgical, thorascopic or laparoscopic access to a body cavity.
I. Devices and Systems
Described here are devices and systems for detaching or decoupling an outer catheter from an implant. For example, a decoupled outer catheter may be removed from a subannular region of the left ventricle of the heart after deployment of the implant from the outer catheter into heart tissue. For example, the outer catheters described here may be used in beating heart procedures where it may be difficult to control the position of the distal end of an anchor delivery catheter with respect to the target tissue. Generally, an outer catheter comprises a plurality of lumens and apertures along a longitudinal axis of the outer catheter. The implant may comprise one or more tissue anchors that may be advanced through a tissue anchor lumen of the outer catheter. The tissue anchors may be coupled together by a tether. A plurality of tissue anchor apertures may be arranged longitudinally at a distal portion of the outer catheter to allow the tissue anchors to be delivered out of corresponding tissue anchor apertures.
In one variation, an implant delivery system may comprise an outer catheter and an inner catheter slidable within the outer catheter. An anchor delivery catheter may be slidable within the inner catheter. Once the outer catheter has been positioned at its desired location, it need not be moved relative to heart tissue to deploy an implant (e.g., a plurality of tissue anchors). Instead, the anchor delivery catheter and/or inner catheter may be manipulated within the non-moving outer catheter to deploy the tissue anchors through a desired tissue anchor aperture. The outer catheter also permits delivery of tissue anchors with predetermined spacing and/or alignment with respect to each other. Thus, the outer catheter may reduce the risk that during a lengthy procedure with multiple anchoring sites, repositioning of the anchor delivery catheter to a new target location may dislodge the anchor delivery catheter and/or the implant from heart tissue.
After deployment of tissue anchors from the outer catheter, portions of the implant (e.g., tether) may be retained within the outer catheter until a mechanism is actuated that allows the tether to be released from the outer catheter. The devices and system discussed below comprise an implant release mechanism that allows the tissue anchors to completely separate and release from the outer catheter with minimal force and physical interference, thereby reducing the risk of damage to the system and tissue. For instance, the implant release mechanism may be operated in a manner where the mechanism does not interfere with any of a tissue anchor, tether, outer catheter, and heart tissue. The implant release mechanism may be easily operated from a hub and may utilize, but need not require, direct or indirect visualization.
One variation is illustrated in the side view of
A hub 250 is coupled to a proximal end of the outer catheter 202. As depicted in
Outer Catheter
A perspective view of the distal portion of outer catheter 202 is illustrated in
An implant release mechanism 208 may be provided between adjacent apertures 204 and include a retaining portion 212 that separates adjacent tissue anchor apertures 204. A first elongate element 214 may extend transversely relative to a longitudinal axis of the outer catheter 202 across an external surface of the outer catheter 202 to hold the retaining portion 212 in a closed configuration that promotes stability of the outer catheter 202 during delivery of an implant (e.g., tissue anchors). As will be discussed in more detail with respect to
Lumens
A guidewire lumen 314 may be provided for a guidewire (not shown) to provide relative movement between the outer catheter 302 and guidewire. For example, the guidewire may first be advanced from the descending aorta, through the left ventricle into subvavular space behind chordae tendineae, and positioned in a subannular groove region. Then, the outer catheter 302 may be advanced over the guidewire to position the outer catheter 302 in the subannular groove region under the mitral valve. Accordingly, the guidewire may be used as a rail for outer catheter placement. Once the outer catheter 302 is advanced to a desired position, the guidewire may remain in place throughout a procedure to facilitate ease of use and safety. For example, the guidewire may function as a rail and a position locator if there is a need to remove and replace the outer catheter during the procedure. Additionally or alternatively, the guidewire may extend out of the distal end of the outer catheter and form an atraumatic tip. Alternatively, once the outer catheter 302 is advanced to a desired position, the guidewire may be withdrawn proximally from the guidewire lumen 314, and out of a guidewire port.
The guidewire lumen 314 may form a circular cross-section at a proximal end of the outer catheter 302 (
In some variations, one or more of the lumens may comprise a liner to reinforce the lumen or provide a friction different than that of the lumen. For example, a lumen may comprise a material such as PEBAX, and a liner may have a high friction coefficient and/or may comprise a material such as PTFE. For instance,
In some variations, the outer catheter 302 may comprise a polymer jacket 316 and/or braid reinforcement 318 to reinforce the outer catheter 302 and/or alter the flexibility of the outer catheter 302. A polymer jacket may be made, for example, from a low stiffness material in order to form a flexible catheter, while the braid reinforcement may be braided with a pitch to improve torque transmission without significantly increasing stiffness. Braid reinforcement 318 may be provided within the polymer jacket 316 in a spaced apart manner away from a lumen side of the outer catheter 302. In some variations, a distal end of the outer catheter 302 may decrease in diameter relative to the proximal end, and may be provided without braid reinforcement. Accordingly, the distal end of the outer catheter 302 may be more flexible than a proximal end of the outer catheter 302.
Inner Catheter
In some variations, an implant delivery system may comprise an inner catheter 320 slidable within a tissue anchor lumen 308 of the outer catheter 302, as shown in
Implant Release Mechanism
An implant release mechanism as depicted in
The outer catheter 400 may further comprise a plurality of tissue anchor apertures 408 along a longitudinal axis of the outer catheter 400. The tissue anchor apertures 408 may open into a tissue anchor lumen of the outer catheter 400. The first and second elongate element lumens 404, 406 are provided parallel to the longitudinal axis of the outer catheter 404 on either side of the tissue anchor apertures 408.
The outer catheter 400 may include one or more first elongate element apertures 414 and second elongate element apertures 416. The first and second elongate element apertures 414, 416 open into respective first and second elongate element lumens 404, 406. The first and second elongate element apertures 414, 416 may be any size and shape that allows the first elongate element 410 to exit and enter the first and second elongate element apertures 414, 416. Adjacent first and second elongate element apertures 414, 416 in the transverse direction with respect to the longitudinal axis are referred to as an elongate element aperture pair.
A retaining portion 418 may be provided between adjacent tissue anchor apertures 408 and an elongate element aperture pair. The retaining portion 418 may comprise a polymer wall structure that separates adjacent tissue anchor apertures 408 and first and second elongate element apertures 414, 416. The retaining portion 418 may comprise a channel 420 that is adapted to be in a locked, closed configuration (
As shown in
The first elongate element 410 may extend into the second elongate element aperture 416 and loop 422 over the second elongate element 412 to couple the first and second elongate elements 410, 412 to each other. The first elongate element 410 may extend out of the second elongate element aperture 416 and extend back across over the external surface of the outer catheter 400, the channel 420, and retaining portion 418. The first elongate element 410 may extend into the first elongate element aperture 414 and back into the first elongate element lumen 404.
A locked configuration of the implant release mechanism refers herein to the configuration shown in
In some variations, the first elongate element 410 extending between the first and second elongate element apertures 414, 416 (over the retaining portion 418) crosses over or intertwines itself, as shown in
In some variations, the first elongate element 410 may be formed of any material that may be looped and tensioned around the second elongate element 412. In some instances, the first elongate element 410 may be a fiber cable such as a flexible, twistable, and/or lubricious cable. In some variations, the first elongate element 410 may be fixed to a distal end of the outer catheter 400 (not shown). In some instances, a distal end of the first elongate element 410 may be terminated in the first elongate element lumen 404 by a knot or any other suitable method such that the first elongate element 410 is fixed and remains secured to the outer catheter 400 when a proximal end of the first elongate element 410 is retracted from the first elongate element lumen 404. This allows the tension of the first elongate element 410 to be controlled when the first elongate element 410 is releasably coupled from the second elongate element 412.
The second elongate element 412 may be formed of any material that may hold its shape as it is looped by and coupled to the first elongate element 410. In some instances, the second elongate element 412 may be a wire such as a metal wire or metal rod, a wire thread, or ribbon formed from metal, polymer, or combination thereof.
A transition of the implant release mechanism 402 from the locked and closed configuration to an unlocked and open configuration will be described with respect to
In
It should be noted that once the second elongate element 412 is retracted, a tether may be released from the outer catheter 400 through the open channel 420 (
The first elongate element 510 may extend into the second elongate element aperture 512 and loop over the second elongate element 514 to couple the first and second elongate elements 510, 514 to each other. The first elongate element 510 may extend out of the second elongate element aperture 512 and extend back across over the external surface of the outer catheter 502 and over retaining portion 506. The first elongate element 510 may extend into the first elongate element aperture 508. The first elongate element 510 extending between the first and second elongate element apertures 508, 512 (over the retaining portion 506) may cross over or intertwine. In this closed configuration of the retaining portion 506, the first elongate element 510 may be looped around the second elongate element 514 to close the retaining portion 506.
The size and shape of the retaining portions described above are not particularly limited. In some variations, a retaining portion may comprise an aperture having substantially the same width as the tissue anchor aperture such that outer catheter may comprise a single continuous tissue anchor aperture. In these variations, the first elongate element extending across the retaining portion may serve as a physical barrier to secure a portion of a tether to the outer catheter.
In some variations, the first elongate element may extend across the retaining portion at an angle with respect to the longitudinal axis of the outer catheter, for example, in a shoelace pattern. Alternatively, an outer wall structure of the retaining portion and the first elongate element may together physically retain a portion of a tether to the outer catheter until actuation of the implant release mechanism.
In other variations, an implant release mechanism may comprise transverse lumens extending through (i.e., within the thickness of) the retaining portions. A transverse lumen may open into both the first and second elongate element lumens to provide a path for the first elongate element to releasably couple to the second elongate element in the second elongate element lumen. The first elongate element may loop over the second elongate element in a similar manner as described above. In this manner, the first elongate element need not travel over an exterior of the outer catheter to loop and secure to the second elongate element. Furthermore, in these variations, first and second elongate element apertures may be removed such that a distal end of the first and second elongate element lumens are not directly open to fluid and/or tissue within a body cavity such as the heart.
Each retaining portion may comprise at least one transverse lumen. In variations where the retaining portion comprises one transverse lumen, the first elongate element may cross over or intertwine itself within the transverse lumen. In variations where the retaining portion comprises two transverse lumens, the first elongate element may extend through a first transverse lumen, couple to the second elongate element in the second elongate element lumen, and then may extend through a second transverse lumen and back into the first elongate element lumen. In some variations, the transverse lumens need not be perpendicular to the first and second elongate element lumens and may be formed at an angle with respect to the longitudinal axis of the outer catheter. In some instances, the transverse lumens may form an “X” shape to allow the first elongate element to cross over or intertwine itself.
Tissue Anchor
Tissue anchors may be secured to tissue (e.g., the heart) using the outer catheters described to releasably retain a tether coupled to the tissue anchors. “Anchors,” as described herein, are defined to mean any fasteners. In some variations, one or more tissue anchors may be loaded into an anchor delivery catheter. An anchor delivery catheter may be advanced through the lumen of an outer catheter described herein and a first tissue anchor may be deployed into heart tissue. The first tissue anchor may be coupled or secured to a tether. The remaining tissue anchors may be slidably coupled to the tether. In some variations, the tether may be in the form of a cable or wire. In this way, after the first tissue anchor is secured to heart tissue, the tether will remain coupled to the first tissue anchor.
While the tether may be used as a track or monorail for the advancement of additional anchor delivery catheters thereover, the tether is also a component of the tissue anchor structure that interconnects the multiple tissue anchors. A portion of the tether may facilitate the tightening of a valve and remain in the body with the tissue anchors after the anchor delivery system is removed from the body. For instance, when pulled proximally while restraining the position of the proximal tissue anchor, the tether may be used to cinch or reduce the circumference of the atrio-ventricular valve annulus or the annular tissue.
In
The first tissue anchor 616 may be deployed from a tissue anchor lumen through the distal-most tissue anchor aperture 604. The second tissue anchor 620 may be deployed through the next distal-most tissue anchor aperture 604. A portion of the tether 618 is retained on a lumen side of the retaining portion 606. As shown in
As shown in
The retaining portions 606 may transition from a closed configuration to an open configuration as explained using
In some variations, the tissue anchors may comprise C-shaped or semicircular hooks, curved hooks of other shapes, straight hooks, barbed hooks, clips of any kind, T-tags, or any other suitable fastener(s). In some variations, tissue anchors may comprise two tips that curve in opposite directions upon deployment, forming two intersecting semi-circles, circles, ovals, helices or the like. In some variations, the tips may be sharpened or beveled.
In some variations, the tissue anchors are self-deforming. By “self-deforming” it is meant that the tissue anchors are biased to change from a first undeployed shape to a second deployed shape upon release of the tissue anchors from an outer catheter. Such self-deforming tissue anchors may change shape as they are released from a housing or deployed from a lumen or opening to enter annular tissue, and secure themselves to the tissue. Self-deforming anchors may be made of any suitable material such as spring stainless steel, or super-elastic or shape-memory material like nickel-titanium alloy (e.g., Nitinol). In some variations, anchors may comprise one or more bioactive agents, including biodegradable metals and, polymers.
In some variations, the tether may be made from any suitable or desirable biocompatible material. The tether may be braided or not braided, woven or not woven, reinforced or impregnated with additional materials, or may be made of a single material or a combination of materials. For example, the tether may be made from a suture material (e.g., absorbable suture materials such as polyglycolic acid and polydioxanone, natural fibers such as silk, and artificial fibers such as ultra-high molecular weight polyethylene (UHMW PE), polypropylene, polyester, polyester impregnated with polytetrafluoroethylene, nylon, polyetheretherketone, etc.), a metal (absorbable or non-absorbable), a metal alloy (e.g., stainless steel), a shape memory material, such as a shape memory alloy (e.g., a nickel titanium alloy), other biocompatible material, or any combination thereof.
Hub
A perspective view of the hub 250 is shown in
Radiopaque Structures
A radiopaque structure may be located between the plurality of apertures opposite the apertures. The radiopaque structures may be visualized indirectly, such as through fluoroscopy. Accordingly, the radiopaque structures 624 (e.g.,
II. Methods
The catheters described herein may be useful for detaching or decoupling an outer catheter from an implant. For example, the methods discussed below may allow removal of an outer catheter from a subannular region of the left ventricle of the heart. Generally, removal of an outer catheter may comprise releasing an implant (e.g., tissue anchors) from the outer catheter. The methods may generally involve positioning an outer catheter adjacent to heart tissue, advancing an anchor delivery catheter within the outer catheter, deploying tissue anchors into heart tissue, releasing the tissue anchors from the outer catheter, and removing the outer catheter from the heart. For instance, an implant release mechanism may be actuated to open a passage for release of the tissue anchors, as described in more detail below.
One variation of a method to detach or decouple an outer catheter from an implant is illustrated in the flowchart 800 of
In
Once the outer catheter 720 is positioned against or near the endocardium 704 through the guide catheter 710, the guidewire may be withdrawn proximally and the outer catheter 720 may direct the placement of an implant, such as heart tissue anchors, into myocardium 706 of the left ventricle 702. For instance, the tissue anchors may be deployed to a depth of about 6 mm. The outer catheter 720 may comprise a plurality of tissue anchor apertures 722 and radiopaque structures 724. The outer catheter 720 may be indirectly visualized through the radiopaque structures 724.
As shown in
A second anchor delivery catheter 730 may then be advanced over the tether 742 through the lumen of the catheter 730. After the second anchor delivery catheter 730 has been advanced over the tether 742 through the lumen of the outer catheter 720, a second tissue anchor 744 may be deployed into the myocardium 706 from a second tissue anchor aperture 722. This process may continue for each of the tissue anchor apertures 722 of outer catheter 720.
In some variations, delivery and deployment of tissue anchors may be achieved by removing and reloading the same anchor delivery catheter 730. In other variations, the anchor delivery catheter may be loaded with a plurality of tissue anchors and does not need to be withdrawn from the outer catheter 720 to deliver subsequent tissue anchors.
It should be appreciated that one or more tissue anchors 740 may be deployed into the annulus directly, while other tissue anchors may be secured to other tissue in the vicinity of the subannular groove region. Tissue anchors 740 may be deployed from the anchor delivery catheter 730 and outer catheter 720 in any suitable fashion, including but not limited to a push-pull wire, using a plunger, or other suitable actuation technique.
Turning back to
Once the second elongate element is retracted, the uncoupled first elongate element 610 may be tensioned to withdraw the first elongate element 610 into the first elongate element lumen of the outer catheter 602, as shown in
It should be noted that prior to introducing the outer catheter into a body cavity, the first elongate element may be crossed over itself and coupled to a second elongate element, as shown in
The procedures described above represents variations that may be used to treat the annular tissue of the mitral valve. In other variations, other tissues or structures of the heart and vasculature can also be treated, including but not limited to the subvalvular apparatus, septal structures, and the myocardium. In still other variations, one or more cinchable implants may be deployed in non-cardiac tissues or structures, for example, to treat gastrointestinal disorders such as obesity, genitourinary conditions such as incontinence, or to perform cosmetic and reconstructive procedures.
While the inventive devices, systems, and methods have been described in some detail by way of illustration, such illustration is for purposes of clarity of understanding only. It will be readily apparent to those of ordinary skill in the art in light of the teachings herein that certain changes and modifications may be made thereto without departing from the spirit and scope of the appended claims.
This application is a continuation of U.S. patent application Ser. No. 15/572,757, having a 371(c) filing date of Nov. 8, 2017, now issued U.S. Pat. No. 10,980,973, which is a U.S. National Phase Application under 35 U.S.C. § 371 of International Application No. PCT/US2016/032220, filed May 12, 2016, which designated the United States, which claims priority to U.S. Provisional Application Ser. No. 62/160,595, filed on May 12, 2015, each of which is hereby incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
2108206 | Sidney | Feb 1938 | A |
3598576 | Moore et al. | Aug 1971 | A |
3656185 | Carpentier | Apr 1972 | A |
3727614 | Kniazuk | Apr 1973 | A |
3773034 | Burns et al. | Nov 1973 | A |
3958576 | Komiya | May 1976 | A |
3961419 | Schwartz | Jun 1976 | A |
3976079 | Samuels et al. | Aug 1976 | A |
4014492 | Rothfuss | Mar 1977 | A |
4034473 | May | Jul 1977 | A |
4042979 | Angell | Aug 1977 | A |
4043504 | Hueil et al. | Aug 1977 | A |
4053979 | Tuthill et al. | Oct 1977 | A |
4055861 | Carpentier et al. | Nov 1977 | A |
4069825 | Akiyama | Jan 1978 | A |
4290151 | Massana | Sep 1981 | A |
4384406 | Tischlinger | May 1983 | A |
4445892 | Hussein et al. | May 1984 | A |
4489446 | Reed | Dec 1984 | A |
4494542 | Lee | Jan 1985 | A |
4619247 | Inoue et al. | Oct 1986 | A |
4700250 | Kuriyama | Oct 1987 | A |
4705040 | Mueller et al. | Nov 1987 | A |
4726371 | Gibbens | Feb 1988 | A |
4758221 | Jureidini | Jul 1988 | A |
4784133 | Mackin | Nov 1988 | A |
4798594 | Hillstead | Jan 1989 | A |
4845851 | Warthen | Jul 1989 | A |
4848341 | Ahmad | Jul 1989 | A |
4850354 | McGurk-Burleson et al. | Jul 1989 | A |
4961738 | Mackin | Oct 1990 | A |
4969893 | Swor | Nov 1990 | A |
4976710 | Mackin | Dec 1990 | A |
5053047 | Yoon | Oct 1991 | A |
5064431 | Gilbertson et al. | Nov 1991 | A |
5078731 | Hayhurst | Jan 1992 | A |
5084058 | Li | Jan 1992 | A |
5103804 | Abele et al. | Apr 1992 | A |
5108368 | Hammerslag et al. | Apr 1992 | A |
5133723 | Li et al. | Jul 1992 | A |
5221255 | Mahurkar et al. | Jun 1993 | A |
5221269 | Miller et al. | Jun 1993 | A |
5242456 | Nash et al. | Sep 1993 | A |
5242457 | Akopov et al. | Sep 1993 | A |
5257975 | Foshee | Nov 1993 | A |
5306296 | Wright et al. | Apr 1994 | A |
5312341 | Turi | May 1994 | A |
5324298 | Phillips et al. | Jun 1994 | A |
5346500 | Suchart | Sep 1994 | A |
5358479 | Wilson | Oct 1994 | A |
5358514 | Schulman et al. | Oct 1994 | A |
5364407 | Poll | Nov 1994 | A |
5366479 | McGarry et al. | Nov 1994 | A |
5368591 | Lennox et al. | Nov 1994 | A |
5383905 | Golds et al. | Jan 1995 | A |
5395316 | Martin | Mar 1995 | A |
5409483 | Campbell et al. | Apr 1995 | A |
5409499 | Yi | Apr 1995 | A |
5417700 | Egan | May 1995 | A |
5423837 | Mericle et al. | Jun 1995 | A |
5437680 | Yoon | Aug 1995 | A |
5439470 | Li | Aug 1995 | A |
5450860 | O'Connor | Sep 1995 | A |
5452513 | Zinnbauer et al. | Sep 1995 | A |
5474572 | Hayhurst | Dec 1995 | A |
5507760 | Wynne et al. | Apr 1996 | A |
5520702 | Sauer et al. | May 1996 | A |
5522873 | Jackman et al. | Jun 1996 | A |
5524630 | Crowley | Jun 1996 | A |
5527323 | Jervis et al. | Jun 1996 | A |
5531686 | Lundquist et al. | Jul 1996 | A |
5531763 | Mastri et al. | Jul 1996 | A |
5545134 | Hilaire et al. | Aug 1996 | A |
5545168 | Burke | Aug 1996 | A |
5565122 | Zinnbauer et al. | Oct 1996 | A |
5571215 | Sterman et al. | Nov 1996 | A |
5591194 | Berthiaume | Jan 1997 | A |
5626590 | Wilk | May 1997 | A |
5626614 | Hart | May 1997 | A |
5630824 | Hart | May 1997 | A |
5643289 | Sauer et al. | Jul 1997 | A |
5669917 | Sauer et al. | Sep 1997 | A |
5674279 | Wright et al. | Oct 1997 | A |
5690655 | Hart et al. | Nov 1997 | A |
5709695 | Northrup, III | Jan 1998 | A |
5713950 | Cox | Feb 1998 | A |
5716370 | Williamson, IV et al. | Feb 1998 | A |
5718725 | Sterman et al. | Feb 1998 | A |
5725542 | Yoon | Mar 1998 | A |
5735290 | Sterman et al. | Apr 1998 | A |
5741260 | Songer et al. | Apr 1998 | A |
5741301 | Pagedas | Apr 1998 | A |
5752518 | McGee et al. | May 1998 | A |
5752964 | Mericle | May 1998 | A |
5752966 | Chang | May 1998 | A |
5755730 | Swain et al. | May 1998 | A |
5766240 | Johnson | Jun 1998 | A |
5769812 | Stevens et al. | Jun 1998 | A |
5782861 | Cragg et al. | Jul 1998 | A |
5810848 | Hayhurst | Sep 1998 | A |
5810853 | Yoon | Sep 1998 | A |
5817107 | Schaller | Oct 1998 | A |
5827171 | Dobak, III et al. | Oct 1998 | A |
5843169 | Taheri | Dec 1998 | A |
5848969 | Panescu et al. | Dec 1998 | A |
5860992 | Daniel et al. | Jan 1999 | A |
5860993 | Thompson et al. | Jan 1999 | A |
5868733 | Ockuly et al. | Feb 1999 | A |
5879371 | Gardiner et al. | Mar 1999 | A |
5885238 | Stevens et al. | Mar 1999 | A |
5888240 | Carpentier et al. | Mar 1999 | A |
5902321 | Caspari et al. | May 1999 | A |
5904651 | Swanson et al. | May 1999 | A |
5906579 | Vander Salm et al. | May 1999 | A |
5911717 | Jacobsen et al. | Jun 1999 | A |
5919207 | Taheri | Jul 1999 | A |
5919208 | Valenti | Jul 1999 | A |
5935149 | Ek | Aug 1999 | A |
5947983 | Solar et al. | Sep 1999 | A |
5961440 | Schweich, Jr. et al. | Oct 1999 | A |
5961539 | Northrup, III et al. | Oct 1999 | A |
5972004 | Williamson, IV et al. | Oct 1999 | A |
5984933 | Yoon | Nov 1999 | A |
5989284 | Laufer | Nov 1999 | A |
5991650 | Swanson et al. | Nov 1999 | A |
6010531 | Donlon et al. | Jan 2000 | A |
6015428 | Pagedas | Jan 2000 | A |
6045497 | Schweich, Jr. et al. | Apr 2000 | A |
6050936 | Schweich, Jr. et al. | Apr 2000 | A |
6056743 | Ellis et al. | May 2000 | A |
6059715 | Schweich, Jr. et al. | May 2000 | A |
6066160 | Colvin et al. | May 2000 | A |
6074401 | Gardiner et al. | Jun 2000 | A |
6077214 | Mortier et al. | Jun 2000 | A |
6077989 | Kandel et al. | Jun 2000 | A |
6099553 | Hart et al. | Aug 2000 | A |
6102945 | Campbell | Aug 2000 | A |
6125852 | Stevens et al. | Oct 2000 | A |
6149658 | Gardiner et al. | Nov 2000 | A |
6152934 | Harper et al. | Nov 2000 | A |
6162168 | Schweich, Jr. et al. | Dec 2000 | A |
6165183 | Kuehn et al. | Dec 2000 | A |
6171329 | Shaw et al. | Jan 2001 | B1 |
6183469 | Thapliyal et al. | Feb 2001 | B1 |
6197017 | Brock et al. | Mar 2001 | B1 |
6203531 | Ockuly et al. | Mar 2001 | B1 |
6221084 | Fleenor | Apr 2001 | B1 |
6228055 | Foerster et al. | May 2001 | B1 |
6228096 | Marchand | May 2001 | B1 |
6250308 | Cox | Jun 2001 | B1 |
6254620 | Koh et al. | Jul 2001 | B1 |
6258118 | Baum et al. | Jul 2001 | B1 |
6260552 | Mortier et al. | Jul 2001 | B1 |
6269819 | Oz et al. | Aug 2001 | B1 |
6283993 | Cosgrove et al. | Sep 2001 | B1 |
6306149 | Meade | Oct 2001 | B1 |
6312447 | Grimes | Nov 2001 | B1 |
6328727 | Frazier et al. | Dec 2001 | B1 |
6332893 | Mortier et al. | Dec 2001 | B1 |
6355030 | Aldrich et al. | Mar 2002 | B1 |
6378289 | Trudeau et al. | Apr 2002 | B1 |
6391048 | Ginn et al. | May 2002 | B1 |
6406420 | McCarthy et al. | Jun 2002 | B1 |
6409743 | Fenton, Jr. | Jun 2002 | B1 |
6423088 | Fenton, Jr. | Jul 2002 | B1 |
6432123 | Schwartz et al. | Aug 2002 | B2 |
6461327 | Addis et al. | Oct 2002 | B1 |
6491689 | Ellis et al. | Dec 2002 | B1 |
6514265 | Ho et al. | Feb 2003 | B2 |
6524328 | Levinson | Feb 2003 | B2 |
6524338 | Gundry | Feb 2003 | B1 |
6533753 | Haarstad et al. | Mar 2003 | B1 |
6551332 | Nguyen et al. | Apr 2003 | B1 |
6575971 | Hauck et al. | Jun 2003 | B2 |
6575987 | Gellman et al. | Jun 2003 | B2 |
6589160 | Schweich, Jr. et al. | Jul 2003 | B2 |
6602288 | Cosgrove et al. | Aug 2003 | B1 |
6602289 | Colvin et al. | Aug 2003 | B1 |
6607541 | Gardiner et al. | Aug 2003 | B1 |
6613059 | Schaller et al. | Sep 2003 | B2 |
6619291 | Hlavka et al. | Sep 2003 | B2 |
6626899 | Houser et al. | Sep 2003 | B2 |
6629534 | St. Goar et al. | Oct 2003 | B1 |
6641593 | Schaller et al. | Nov 2003 | B1 |
6648903 | Pierson, III | Nov 2003 | B1 |
6651671 | Donlon et al. | Nov 2003 | B1 |
6655386 | Makower et al. | Dec 2003 | B1 |
6669687 | Saadat | Dec 2003 | B1 |
6676702 | Mathis | Jan 2004 | B2 |
6689164 | Seguin | Feb 2004 | B1 |
6699263 | Cope | Mar 2004 | B2 |
6702826 | Liddicoat et al. | Mar 2004 | B2 |
6716243 | Colvin et al. | Apr 2004 | B1 |
6718985 | Hlavka et al. | Apr 2004 | B2 |
6723038 | Schroeder et al. | Apr 2004 | B1 |
6723107 | Skiba et al. | Apr 2004 | B1 |
6733509 | Nobles et al. | May 2004 | B2 |
6746457 | Dana et al. | Jun 2004 | B2 |
6749622 | McGuckin, Jr. et al. | Jun 2004 | B2 |
6752813 | Goldfarb et al. | Jun 2004 | B2 |
6790231 | Liddicoat et al. | Sep 2004 | B2 |
6793618 | Schweich, Jr. et al. | Sep 2004 | B2 |
6802851 | Jones et al. | Oct 2004 | B2 |
6811560 | Jones et al. | Nov 2004 | B2 |
6818001 | Wulfman et al. | Nov 2004 | B2 |
6875224 | Grimes | Apr 2005 | B2 |
6908424 | Mortier et al. | Jun 2005 | B2 |
6923818 | Muramatsu et al. | Aug 2005 | B2 |
6932792 | St. Goar et al. | Aug 2005 | B1 |
6951557 | Ellis et al. | Oct 2005 | B2 |
6986775 | Morales et al. | Jan 2006 | B2 |
6991643 | Saadat | Jan 2006 | B2 |
6997931 | Sauer et al. | Feb 2006 | B2 |
7004958 | Adams et al. | Feb 2006 | B2 |
7037334 | Hlavka et al. | May 2006 | B1 |
7044957 | Foerster et al. | May 2006 | B2 |
7048754 | Martin et al. | May 2006 | B2 |
7101395 | Tremulis et al. | Sep 2006 | B2 |
7125421 | Tremulis et al. | Oct 2006 | B2 |
7166127 | Spence et al. | Jan 2007 | B2 |
7186262 | Saadat | Mar 2007 | B2 |
7186264 | Liddicoat et al. | Mar 2007 | B2 |
7189199 | McCarthy et al. | Mar 2007 | B2 |
7235086 | Sauer et al. | Jun 2007 | B2 |
7241310 | Taylor et al. | Jul 2007 | B2 |
7326231 | Phillips et al. | Feb 2008 | B2 |
7335213 | Hyde et al. | Feb 2008 | B1 |
7344544 | Bender et al. | Mar 2008 | B2 |
7452325 | Schaller | Nov 2008 | B2 |
7534204 | Starksen et al. | May 2009 | B2 |
7588582 | Starksen et al. | Sep 2009 | B2 |
7618449 | Tremulis et al. | Nov 2009 | B2 |
7655040 | Douk et al. | Feb 2010 | B2 |
7666193 | Starksen et al. | Feb 2010 | B2 |
7727247 | Kimura et al. | Jun 2010 | B2 |
7753858 | Starksen et al. | Jul 2010 | B2 |
7753922 | Starksen | Jul 2010 | B2 |
7753924 | Starksen et al. | Jul 2010 | B2 |
7758637 | Starksen et al. | Jul 2010 | B2 |
7766812 | Schroeder et al. | Aug 2010 | B2 |
7832406 | Ellis et al. | Nov 2010 | B2 |
7850600 | Piskun | Dec 2010 | B1 |
7883538 | To et al. | Feb 2011 | B2 |
7918787 | Saadat | Apr 2011 | B2 |
7922762 | Starksen | Apr 2011 | B2 |
7993368 | Gambale et al. | Aug 2011 | B2 |
8066766 | To et al. | Nov 2011 | B2 |
8287555 | Starksen et al. | Oct 2012 | B2 |
8287557 | To et al. | Oct 2012 | B2 |
8343173 | Starksen et al. | Jan 2013 | B2 |
8641727 | Starksen et al. | Feb 2014 | B2 |
8790367 | Nguyen et al. | Jul 2014 | B2 |
9072513 | To et al. | Jul 2015 | B2 |
9226825 | Starksen et al. | Jan 2016 | B2 |
9468528 | Starksen et al. | Oct 2016 | B2 |
9706996 | Nguyen et al. | Jul 2017 | B2 |
9949829 | Starksen et al. | Apr 2018 | B2 |
10092402 | Starksen et al. | Oct 2018 | B2 |
10542987 | Nguyen et al. | Jan 2020 | B2 |
10624741 | Starksen et al. | Apr 2020 | B2 |
10980973 | Nguyen et al. | Apr 2021 | B2 |
20010005787 | Oz et al. | Jun 2001 | A1 |
20010014800 | Frazier et al. | Aug 2001 | A1 |
20010023332 | Hahnen | Sep 2001 | A1 |
20010031979 | Ricci | Oct 2001 | A1 |
20010034528 | Foerster et al. | Oct 2001 | A1 |
20010041821 | Wilk | Nov 2001 | A1 |
20020013571 | Goldfarb et al. | Jan 2002 | A1 |
20020013621 | Stobie et al. | Jan 2002 | A1 |
20020026201 | Foerster et al. | Feb 2002 | A1 |
20020029080 | Mortier et al. | Mar 2002 | A1 |
20020035361 | Houser et al. | Mar 2002 | A1 |
20020042621 | Liddicoat et al. | Apr 2002 | A1 |
20020065536 | Hart et al. | May 2002 | A1 |
20020072757 | Ahmed et al. | Jun 2002 | A1 |
20020077524 | Schweich, Jr. et al. | Jun 2002 | A1 |
20020087048 | Brock et al. | Jul 2002 | A1 |
20020087049 | Brock et al. | Jul 2002 | A1 |
20020087148 | Brock et al. | Jul 2002 | A1 |
20020087169 | Brock et al. | Jul 2002 | A1 |
20020095167 | Liddicoat et al. | Jul 2002 | A1 |
20020095175 | Brock et al. | Jul 2002 | A1 |
20020095180 | West, Jr. et al. | Jul 2002 | A1 |
20020138044 | Streeter et al. | Sep 2002 | A1 |
20020156526 | Hlavka et al. | Oct 2002 | A1 |
20020161378 | Downing | Oct 2002 | A1 |
20020165486 | Bertolero et al. | Nov 2002 | A1 |
20020165561 | Ainsworth et al. | Nov 2002 | A1 |
20020173841 | Ortiz et al. | Nov 2002 | A1 |
20020183787 | Wahr et al. | Dec 2002 | A1 |
20020183835 | Taylor et al. | Dec 2002 | A1 |
20020193815 | Foerster et al. | Dec 2002 | A1 |
20030009196 | Peterson | Jan 2003 | A1 |
20030014060 | Wilson, Jr. et al. | Jan 2003 | A1 |
20030018358 | Saadat | Jan 2003 | A1 |
20030032979 | Mortier et al. | Feb 2003 | A1 |
20030033006 | Phillips et al. | Feb 2003 | A1 |
20030060813 | Loeb et al. | Mar 2003 | A1 |
20030069593 | Tremulis et al. | Apr 2003 | A1 |
20030074012 | Nguyen et al. | Apr 2003 | A1 |
20030078465 | Pai et al. | Apr 2003 | A1 |
20030078601 | Shikhman et al. | Apr 2003 | A1 |
20030078603 | Schaller et al. | Apr 2003 | A1 |
20030093118 | Ho et al. | May 2003 | A1 |
20030105520 | Alferness et al. | Jun 2003 | A1 |
20030125739 | Bagga et al. | Jul 2003 | A1 |
20030125767 | Collier et al. | Jul 2003 | A1 |
20030130731 | Vidlund et al. | Jul 2003 | A1 |
20030144697 | Mathis et al. | Jul 2003 | A1 |
20030158464 | Bertolero | Aug 2003 | A1 |
20030158581 | Levinson | Aug 2003 | A1 |
20030167062 | Gambale et al. | Sep 2003 | A1 |
20030167071 | Martin et al. | Sep 2003 | A1 |
20030181800 | Bonutti | Sep 2003 | A1 |
20030199974 | Lee et al. | Oct 2003 | A1 |
20030220685 | Hlavka et al. | Nov 2003 | A1 |
20030225420 | Wardle | Dec 2003 | A1 |
20030233105 | Gayton | Dec 2003 | A1 |
20030233142 | Morales et al. | Dec 2003 | A1 |
20030236535 | Onuki et al. | Dec 2003 | A1 |
20040003819 | St. Goar et al. | Jan 2004 | A1 |
20040019378 | Hlavka et al. | Jan 2004 | A1 |
20040024414 | Downing | Feb 2004 | A1 |
20040030382 | St. Goar et al. | Feb 2004 | A1 |
20040039442 | St. Goar et al. | Feb 2004 | A1 |
20040092962 | Thornton et al. | May 2004 | A1 |
20040093024 | Lousararian et al. | May 2004 | A1 |
20040097788 | Mourlas et al. | May 2004 | A1 |
20040122450 | Oren et al. | Jun 2004 | A1 |
20040152947 | Schroeder et al. | Aug 2004 | A1 |
20040162465 | Carrillo | Aug 2004 | A1 |
20040172046 | Hlavka et al. | Sep 2004 | A1 |
20040181238 | Zarbatany et al. | Sep 2004 | A1 |
20040186378 | Gesswein | Sep 2004 | A1 |
20040193191 | Starksen et al. | Sep 2004 | A1 |
20040204724 | Kissel et al. | Oct 2004 | A1 |
20040210238 | Nobles et al. | Oct 2004 | A1 |
20040236372 | Anspach, III et al. | Nov 2004 | A1 |
20040236419 | Milo | Nov 2004 | A1 |
20040243227 | Starksen et al. | Dec 2004 | A1 |
20050021054 | Ainsworth et al. | Jan 2005 | A1 |
20050055052 | Lombardo et al. | Mar 2005 | A1 |
20050055087 | Starksen | Mar 2005 | A1 |
20050065550 | Starksen et al. | Mar 2005 | A1 |
20050065589 | Schneider et al. | Mar 2005 | A1 |
20050075723 | Schroeder et al. | Apr 2005 | A1 |
20050080454 | Drews et al. | Apr 2005 | A1 |
20050107810 | Morales et al. | May 2005 | A1 |
20050107811 | Starksen et al. | May 2005 | A1 |
20050107812 | Starksen et al. | May 2005 | A1 |
20050107871 | Realyvasquez et al. | May 2005 | A1 |
20050119523 | Starksen et al. | Jun 2005 | A1 |
20050119673 | Gordon et al. | Jun 2005 | A1 |
20050137689 | Salahieh et al. | Jun 2005 | A1 |
20050177180 | Kaganov et al. | Aug 2005 | A1 |
20050184122 | Hlavka et al. | Aug 2005 | A1 |
20050192599 | Demarais | Sep 2005 | A1 |
20050192629 | Saadat et al. | Sep 2005 | A1 |
20050197694 | Pai et al. | Sep 2005 | A1 |
20050209690 | Mathis et al. | Sep 2005 | A1 |
20050216078 | Starksen et al. | Sep 2005 | A1 |
20050228452 | Mourlas et al. | Oct 2005 | A1 |
20050251157 | Saadat et al. | Nov 2005 | A1 |
20050251159 | Ewers et al. | Nov 2005 | A1 |
20050251166 | Vaughan et al. | Nov 2005 | A1 |
20050251177 | Saadat et al. | Nov 2005 | A1 |
20050251205 | Ewers et al. | Nov 2005 | A1 |
20050251207 | Flores et al. | Nov 2005 | A1 |
20050251208 | Elmer et al. | Nov 2005 | A1 |
20050251209 | Saadat et al. | Nov 2005 | A1 |
20050251210 | Westra et al. | Nov 2005 | A1 |
20050267495 | Ginn et al. | Dec 2005 | A1 |
20050273138 | To et al. | Dec 2005 | A1 |
20050277966 | Ewers et al. | Dec 2005 | A1 |
20050277981 | Maahs et al. | Dec 2005 | A1 |
20050277983 | Saadat et al. | Dec 2005 | A1 |
20060015144 | Burbank et al. | Jan 2006 | A1 |
20060025750 | Starksen et al. | Feb 2006 | A1 |
20060025784 | Starksen et al. | Feb 2006 | A1 |
20060025787 | Morales et al. | Feb 2006 | A1 |
20060058817 | Starksen et al. | Mar 2006 | A1 |
20060069429 | Spence et al. | Mar 2006 | A1 |
20060122633 | To et al. | Jun 2006 | A1 |
20060129188 | Starksen et al. | Jun 2006 | A1 |
20060161040 | McCarthy et al. | Jul 2006 | A1 |
20060178682 | Boehlke | Aug 2006 | A1 |
20060184203 | Martin et al. | Aug 2006 | A1 |
20060190030 | To et al. | Aug 2006 | A1 |
20060241656 | Starksen et al. | Oct 2006 | A1 |
20060264975 | Pipenhagen et al. | Nov 2006 | A1 |
20060271101 | Saadat et al. | Nov 2006 | A1 |
20060282161 | Huynh et al. | Dec 2006 | A1 |
20060287661 | Bolduc et al. | Dec 2006 | A1 |
20070005081 | Findlay, III et al. | Jan 2007 | A1 |
20070005394 | Bleyendaal et al. | Jan 2007 | A1 |
20070010857 | Sugimoto et al. | Jan 2007 | A1 |
20070032820 | Chin-Chen et al. | Feb 2007 | A1 |
20070038293 | St.Goar et al. | Feb 2007 | A1 |
20070049942 | Hindrichs et al. | Mar 2007 | A1 |
20070051377 | Douk et al. | Mar 2007 | A1 |
20070055206 | To et al. | Mar 2007 | A1 |
20070112244 | McCarthy et al. | May 2007 | A1 |
20070112422 | Dehdashtian | May 2007 | A1 |
20070112424 | Spence et al. | May 2007 | A1 |
20070112425 | Schaller et al. | May 2007 | A1 |
20080045977 | To et al. | Feb 2008 | A1 |
20080045982 | To et al. | Feb 2008 | A1 |
20080045983 | To et al. | Feb 2008 | A1 |
20080051810 | To et al. | Feb 2008 | A1 |
20080051832 | To et al. | Feb 2008 | A1 |
20080051837 | To et al. | Feb 2008 | A1 |
20080058765 | Jais et al. | Mar 2008 | A1 |
20080058868 | To et al. | Mar 2008 | A1 |
20080172035 | Starksen et al. | Jul 2008 | A1 |
20080177380 | Starksen et al. | Jul 2008 | A1 |
20080228032 | Starksen et al. | Sep 2008 | A1 |
20080234701 | Morales et al. | Sep 2008 | A1 |
20080234702 | Morales et al. | Sep 2008 | A1 |
20080234704 | Starksen et al. | Sep 2008 | A1 |
20080234728 | Starksen et al. | Sep 2008 | A1 |
20080234815 | Starksen | Sep 2008 | A1 |
20080243150 | Starksen et al. | Oct 2008 | A1 |
20080294177 | To et al. | Nov 2008 | A1 |
20080312712 | Penner | Dec 2008 | A1 |
20090054824 | Melsheimer et al. | Feb 2009 | A1 |
20090182417 | Tremulis et al. | Jul 2009 | A1 |
20090222083 | Nguyen et al. | Sep 2009 | A1 |
20090234318 | Loulmet et al. | Sep 2009 | A1 |
20090276038 | Tremulis et al. | Nov 2009 | A1 |
20100049213 | Serina et al. | Feb 2010 | A1 |
20100076548 | Konno | Mar 2010 | A1 |
20100082098 | Starksen et al. | Apr 2010 | A1 |
20100094248 | Nguyen et al. | Apr 2010 | A1 |
20100094314 | Hernlund et al. | Apr 2010 | A1 |
20100121349 | Meier et al. | May 2010 | A1 |
20100198192 | Serina et al. | Aug 2010 | A1 |
20110160528 | Starksen | Jun 2011 | A1 |
20120101442 | Legaspi et al. | Apr 2012 | A1 |
20120271331 | To et al. | Oct 2012 | A1 |
20130304093 | Serina et al. | Nov 2013 | A1 |
20140135799 | Henderson | May 2014 | A1 |
20140148849 | Serina et al. | May 2014 | A1 |
20140155783 | Starksen et al. | Jun 2014 | A1 |
20140188140 | Meier et al. | Jul 2014 | A1 |
20140194976 | Starksen et al. | Jul 2014 | A1 |
20150164639 | Starksen et al. | Jun 2015 | A1 |
20150182216 | Morales et al. | Jul 2015 | A1 |
20170224489 | Starksen et al. | Aug 2017 | A1 |
20190091023 | Starksen et al. | Mar 2019 | A1 |
20200229820 | Nguyen et al. | Jul 2020 | A1 |
Number | Date | Country |
---|---|---|
103690202 | Apr 2014 | CN |
0363661 | Apr 1990 | EP |
0669101 | Aug 1995 | EP |
1370546 | Oct 1974 | GB |
H06510460 | Nov 1994 | JP |
H11506628 | Jun 1999 | JP |
2004000601 | Jan 2004 | JP |
2007514455 | Jun 2007 | JP |
4823295 | Nov 2011 | JP |
WO-9308740 | May 1993 | WO |
WO-9403227 | Feb 1994 | WO |
WO-9515715 | Jun 1995 | WO |
WO-9608208 | Mar 1996 | WO |
WO-9639081 | Dec 1996 | WO |
WO-9639942 | Dec 1996 | WO |
WO-9727799 | Aug 1997 | WO |
WO-9727807 | Aug 1997 | WO |
WO-9730639 | Aug 1997 | WO |
WO-9807375 | Feb 1998 | WO |
WO-0060995 | Oct 2000 | WO |
WO-0067640 | Nov 2000 | WO |
WO-0126586 | Apr 2001 | WO |
WO-0154618 | Aug 2001 | WO |
WO-0203892 | Jan 2002 | WO |
WO-0234167 | May 2002 | WO |
WO-02051329 | Jul 2002 | WO |
WO-02053011 | Jul 2002 | WO |
WO-02085251 | Oct 2002 | WO |
WO-02085252 | Oct 2002 | WO |
WO-03088875 | Oct 2003 | WO |
WO-03105667 | Dec 2003 | WO |
WO-03105670 | Dec 2003 | WO |
WO-2004037317 | May 2004 | WO |
WO-2004082523 | Sep 2004 | WO |
WO-2004082538 | Sep 2004 | WO |
WO-2005025644 | Mar 2005 | WO |
WO-2005062931 | Jul 2005 | WO |
WO-2005102181 | Nov 2005 | WO |
WO-2006037073 | Apr 2006 | WO |
WO-2006097931 | Sep 2006 | WO |
WO-2006116558 | Nov 2006 | WO |
WO-2007001936 | Jan 2007 | WO |
WO-2007005495 | Jan 2007 | WO |
WO-2007021564 | Feb 2007 | WO |
WO-2007021834 | Feb 2007 | WO |
WO-2007035449 | Mar 2007 | WO |
WO-2007056502 | May 2007 | WO |
WO-2007100409 | Sep 2007 | WO |
WO-2008028135 | Mar 2008 | WO |
WO-2009100242 | Aug 2009 | WO |
WO-2012031204 | Mar 2012 | WO |
WO-2013112944 | Aug 2013 | WO |
WO-2014183178 | Nov 2014 | WO |
Entry |
---|
Extended European Search Report for European Application No. EP22155112.0 dated Sep. 19, 2022, 12 Pages. |
De Simone, R. et al. (Apr. 1, 1994). “Adjustable Annuloplasty for Tricuspid Insufficiency with External Control,” Reader's Comments and Reply, Am. J. Cardiol. 73(9):721-722. |
De Simone, R. et al. (Apr. 15, 1993). “Adjustable Tricuspid Valve Annuloplasty Assisted by Intraoperative Transesophageal Color Doppler Echocardiography,” Am. J. Cardiol. 71(11):926-931. |
Downing, S.W. et al. (2002). “Feasibility of Off-Pump ASD Closure Using Real-Time 3-D Echocardiography,” The Heart Surgery Forum 5(2):96-99, Abstract 7025. |
European Examination Communication dated Dec. 8, 2009, for EP Application No. 06 837 222.6 filed on Nov. 8, 2006, 3 pages. |
Extended European Search Report dated Sep. 16, 2011, for EP Patent Application No. 11158898.4, filed on Sep. 1, 2004, 8 pages. |
Extended European Search Report dated Sep. 9, 2011, for EP Patent Application No. 11158896.8, filed on Sep. 1, 2004, 7 pages. |
Extended European Search Report dated Jan. 21, 2019, for EP Patent Application No. 16793570.9, filed on May 12, 2016, 2 pages. |
Extended European Search Report dated Dec. 12, 2018, for EP Patent Application No. 18170269.7, filed on Sep. 1, 2004, 2 pages. |
Final Office Action dated Apr. 10, 2009, for U.S. Appl. No. 11/255,400, filed Oct. 20, 2005, 8 pages. |
Final Office Action dated Apr. 10, 2009, for U.S. Appl. No. 11/414,657, filed Apr. 27, 2006, 8 pages. |
Final Office Action dated Apr. 14, 2008, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 11 pages. |
Final Office Action dated Apr. 15, 2016, for U.S. Appl. No. 14/309,837, filed Jun. 19, 2014, 5 pages. |
Final Office Action dated Apr. 2, 2008, for U.S. Appl. No. 10/792,681, filed Mar. 2, 2004, 15 pages. |
Final Office Action dated Apr. 20, 2011, for U.S. Appl. No. 11/414,657, filed Apr. 27, 2006, 8 pages. |
Final Office Action dated Apr. 29, 2009, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 9 pages. |
Final Office Action dated Aug. 1, 2008, for U.S. Appl. No. 11/232,190, filed Sep. 20, 2005, 8 pages. |
Final Office Action dated Aug. 13, 2007, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 9 pages. |
Final Office Action dated Aug. 14, 2007, for U.S. Appl. No. 11/255,400, filed Oct. 20, 2005, 8 pages. |
Final Office Action dated Aug. 30, 2007, for U.S. Appl. No. 11/232,190, filed Sep. 20, 2005, 9 pages. |
Final Office Action dated Aug. 4, 2011, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 9 pages. |
Final Office Action dated Aug. 6, 2007, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 12 pages. |
Final Office Action dated Aug. 6, 2007, for U.S. Appl. No. 11/137,833, filed May 24, 2005, 8 pages. |
Final Office Action dated Dec. 6, 2011, for U.S. Appl. No. 12/366,553, filed Feb. 5, 2009, 7 pages. |
Final Office Action dated Feb. 24, 2011, for U.S. Appl. No. 11/894,397, filed Aug. 20, 2007, 12 pages. |
Final Office Action dated Feb. 24, 2011, for U.S. Appl. No. 11/894,468, filed Aug. 20, 2007, 12 pages. |
Final Office Action dated Feb. 4, 2016, for U.S. Appl. No. 14/626,826, filed Feb. 19, 2015, 9 pages. |
Final Office Action dated Feb. 5, 2015, for U.S. Appl. No. 13/540,499, filed Jul. 2, 2012, 10 pages. |
Final Office Action dated Feb. 6, 2007, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 8 pages. |
Final Office Action dated Jan. 22, 2009, for U.S. Appl. No. 11/255,400, filed Oct. 20, 2005, 9 pages. |
Final Office Action dated Jul. 12, 2007, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 10 pages. |
Final Office Action dated Jul. 21, 2009, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 8 pages. |
Final Office Action dated Jul. 24, 2007, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 10 pages. |
Final Office Action dated Jul. 26, 2010, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 8 pages. |
Final Office Action dated Jun. 11, 2012, for U.S. Appl. No. 12/132,161, filed Jun. 3, 2008, 13 pages. |
Final Office Action dated Jun. 11, 2012, for U.S. Appl. No. 12/187,331, filed Jun. 6, 2008, 7 pages. |
Final Office Action dated Jun. 4, 2008, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 10 pages. |
Final Office Action dated Jun. 8, 2010, for U.S. Appl. No. 10/792,681, filed Mar. 2, 2004, 17 pages. |
Final Office Action dated Mar. 11, 2009, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 10 pages. |
Final Office Action dated Mar. 17, 2011, for U.S. Appl. No. 10/901,554, filed Jul. 27, 2004, 13 pages. |
Final Office Action dated Mar. 17, 2011, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 9 pages. |
Final Office Action dated Mar. 19, 2012, for U.S. Appl. No. 12/574,563, filed Oct. 6, 2009, 6 pages. |
Final Office Action dated Mar. 25, 2010, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 8 pages. |
Final Office Action dated Mar. 3, 2010, for U.S. Appl. No. 11/414,657, filed Apr. 27, 2006, 7 pages. |
Final Office Action dated May 28, 2008, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 10 pages. |
Final Office Action dated Nov. 10, 2009, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 9 pages. |
Final Office Action dated Nov. 10, 2011, for U.S. Appl. No. 10/792,681, filed Mar. 2, 2004, 20 pages. |
Final Office Action dated Nov. 26, 2010, for U.S. Appl. No. 11/894,340, filed Aug. 20, 2007, 12 pages. |
Final Office Action dated Nov. 29, 2010, for U.S. Appl. No. 11/894,463, filed Aug. 20, 2007, 12 pages. |
Final Office Action dated Nov. 3, 2017, for U.S. Appl. No. 13/540,499, filed Jul. 2, 2012, 10 pages. |
Final Office Action dated Oct. 13, 2009, for U.S. Appl. No. 10/901,554, filed Jul. 27, 2004, 11 pages. |
Final Office Action dated Oct. 14, 2008, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 9 pages. |
Final Office Action dated Oct. 30, 2007, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 6 pages. |
Final Office Action dated Oct. 6, 2010, for U.S. Appl. No. 12/132,375, filed Jun. 3, 2008, 9 pages. |
Final Office Action dated Sep. 14, 2017, for U.S. Appl. No. 14/626,826, filed Feb. 19, 2015, 8 pages. |
Final Office Action dated Sep. 15, 2010, for U.S. Appl. No. 11/894,401, filed Aug. 20, 2007, 6 pages. |
Final Office Action dated Sep. 2, 2009, for U.S. Appl. No. 11/232,190, filed Sep. 20, 2005, 8 pages. |
Final Office Action dated Sep. 28, 2009, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 10 pages. |
Final Office Action dated Sep. 30, 2008, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 7 pages. |
Final Office Action dated Jun. 11, 2012, for U.S. Appl. No. 14/626,826, filed Feb. 19, 2015, 7 pages. |
Final Office Action dated Sep. 3, 2020, for U.S. Appl. No. 15/572,757, filed Nov. 8, 2017, 6 pages. |
International Search Report dated Nov. 17, 2016 in PCT Application No. PCT/US2016/032220 filed May 12, 2016. 2 pages. |
International Search Report dated Dec. 19, 2006, for PCT Application No. PCT/US2006/031190, filed Aug. 10, 2006, 4 pages. |
International Search Report dated Apr. 2, 2007, for PCT Application No. PCT/US2006/043597, filed Nov. 8, 2006, 7 pages. |
International Search Report dated Mar. 7, 2007, for PCT Patent Application No. PCT/US2004/028431, filed on Sep. 1, 2004, 1 page. |
International Search Report dated Sep. 15, 2009, for PCT Patent Application No. PCT/US2009/033252, filed on Feb. 5, 2009, 1 page. |
Nagy, Z.L. et al. (Dec. 2000). “Mitral Annuloplasty with a Suture Technique,” European Journal of Cardio-thoracic Surgery 18(6):739-740. |
Non-Final Office Action (Supplementary) dated May 9, 2008, for U.S. Appl. No. 11/255,400, filed Oct. 20, 2005, 7 pages. |
Non-Final Office Action dated Apr. 2, 2010, for U.S. Appl. No. 12/132,375, filed Jun. 3, 2008, 9 pages. |
Non-Final Office Action dated Apr. 21, 2016, for U.S. Appl. No. 13/540,499, filed Jul. 2, 2012, 13 pages. |
Non-Final Office Action dated Apr. 27, 2011, for U.S. Appl. No. 12/366,553, filed Feb. 5, 2009, 9 pages. |
Non-Final Office Action dated Apr. 8, 2013, for U.S. Appl. No. 11/414,657, filed Apr. 27, 2006, 9 pages. |
Non-Final Office Action dated Aug. 1, 2007, for U.S. Appl. No. 10/792,681, filed Mar. 2, 2004, 16 pages. |
Non-Final Office Action dated Aug. 17, 2010, for U.S. Appl. No. 11/414,657, filed Apr. 27, 2006, 7 pages. |
Non-Final Office Action dated Aug. 20, 2010, for U.S. Appl. No. 10/901,554, filed Jul. 27, 2004, 13 pages. |
Non-Final Office Action dated Aug. 22, 2006, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 6 pages. |
Non-Final Office Action dated Aug. 25, 2009, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 7 pages. |
Non-Final Office Action dated Aug. 26, 2009, for U.S. Appl. No. 11/414,657, filed Apr. 27, 2006, 6 pages. |
Non-Final Office Action dated Aug. 29, 2008, for U.S. Appl. No. 10/792,681, filed Mar. 2, 2004, 15 pages. |
Non-Final Office Action dated Aug. 30, 2007, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 10 pages. |
Non-Final Office Action dated Aug. 9, 2006, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 17 pages. |
Non-Final Office Action dated Dec. 22, 2011, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 9 pages. |
Non-Final Office Action dated Dec. 27, 2006, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 9 pages. |
Non-Final Office Action dated Dec. 27, 2006, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 8 pages. |
Non-Final Office Action dated Feb. 10, 2014, for U.S. Appl. No. 12/366,553, filed Feb. 5, 2009, 7 pages. |
Non-Final Office Action dated Feb. 17, 2017, for U.S. Appl. No. 14/626,826, filed Feb. 19, 2015, 11 pages. |
Non-Final Office Action dated Feb. 18, 2010, for U.S. Appl. No. 11/894,401, filed Aug. 20, 2007, 6 pages. |
Non-Final Office Action dated Feb. 2, 2011, for U.S. Appl. No. 12/581,040, filed Oct. 16, 2009, 5 pages. |
Non-Final Office Action dated Feb. 27, 2007, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 8 pages. |
Non-Final Office Action dated Jan. 13, 2009, for U.S. Appl. No. 10/901,555, filed Jul. 27, 2004, 11 pages. |
Non-Final Office Action dated Jan. 19, 2010, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 10 pages. |
Non-Final Office Action dated Jan. 23, 2009, for U.S. Appl. No. 11/232,190, filed Sep. 20, 2005, 8 pages. |
Non-Final Office Action dated Jan. 23, 2009, for U.S. Appl. No. 11/270,034, filed Nov. 8, 2005, 8 pages. |
Non-Final Office Action dated Jan. 26, 2017, for U.S. Appl. No. 13/540,499, filed Jul. 2, 2012, 10 pages. |
Non-Final Office Action dated Jan. 29, 2009, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 6 pages. |
Non-Final Office Action dated Jan. 31, 2008, for U.S. Appl. No. 11/255,400, filed Oct. 20, 2005, 7 pages. |
Non-Final Office Action dated Jan. 4, 2007, for U.S. Appl. No. 11/255,400, filed Oct. 20, 2005, 7 pages. |
Non-Final Office Action dated Jan. 9, 2008, for U.S. Appl. No. 11/232,190, filed Sep. 20, 2005, 8 pages. |
Non-Final Office Action dated Jul. 24, 2007, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 6 pages. |
Non-Final Office Action dated Jul. 29, 2011, for U.S. Appl. No. 12/574,563, filed Oct. 6, 2009, 5 pages. |
Non-Final Office Action dated Jun. 21, 2010, for U.S. Appl. No. 11/894,397, filed Aug. 20, 2007, 13 pages. |
Non-Final Office Action dated Jun. 6, 2008, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 5 pages. |
Non-Final Office Action dated Jun. 9, 2010, for U.S. Appl. No. 11/894,468, filed Aug. 20, 2007, 14 pages. |
Non-Final Office Action dated Mar. 12, 2007, for U.S. Appl. No. 11/232,190, filed Sep. 20, 2005, 11 pages. |
Non-Final Office Action dated Mar. 16, 2010, for U.S. Appl. No. 11/894,340, filed Aug. 20, 2007, 14 pages. |
Non-Final Office Action dated Mar. 18, 2009, for U.S. Appl. No. 10/901,554, filed Jul. 27, 2004, 12 pages. |
Non-Final Office Action dated Mar. 27, 2008, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 7 pages. |
Non-Final Office Action dated Mar. 27, 2009, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 9 pages. |
Non-Final Office Action dated Mar. 29, 2010, for U.S. Appl. No. 11/894,463, filed Aug. 20, 2007, 14 pages. |
Non-Final Office Action dated Mar. 31, 2009, for U.S. Appl. No. 10/792,681, filed Mar. 2, 2004, 15 pages. |
Non-Final Office Action dated Mar. 5, 2009, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 10 pages. |
Non-Final Office Action dated Nov. 14, 2007, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 8 pages. |
Non-Final Office Action dated Nov. 14, 2007, for U.S. Appl. No. 11/137,833, filed May 24, 2005, 8 pages. |
Non-Final Office Action dated Nov. 15, 2006, for U.S. Appl. No. 11/137,833, filed May 24, 2005, 12 pages. |
Non-Final Office Action dated Nov. 24, 2010, for U.S. Appl. No. 10/900,980, filed Jul. 27, 2004, 8 pages. |
Non-Final Office Action dated Nov. 24, 2015, for U.S. Appl. No. 14/156,347, filed Jan. 15, 2014, 5 pages. |
Non-Final Office Action dated Nov. 28, 2006, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 20 pages. |
Non-Final Office Action dated Oct. 13, 2011, for U.S. Appl. No. 12/187,331, filed Aug. 6, 2008, 5 pages. |
Non-Final Office Action dated Oct. 19, 2007, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 7 pages. |
Non-Final Office Action dated Oct. 19, 2009, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 21 pages. |
Non-Final Office Action dated Oct. 19, 2015, for U.S. Appl. No. 14/309,837, filed Jun. 19, 2014, 6 pages. |
Non-Final Office Action dated Oct. 24, 2008, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 11 pages. |
Non-Final Office Action dated Oct. 25, 2010, for U.S. Appl. No. 11/202,474, filed Aug. 11, 2005, 8 pages. |
Non-Final Office Action dated Oct. 29, 2007, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 10 pages. |
Non-Final Office Action dated Oct. 29, 2010, for U.S. Appl. No. 11/894,530, filed Aug. 20, 2007, 11 pages. |
Non-Final Office Action dated Sep. 17, 2009, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 13 pages. |
Non-Final Office Action dated Sep. 26, 2008, for U.S. Appl. No. 11/414,657, filed Apr. 27, 2006, 11 pages. |
Non-Final Office Action dated Mar. 28, 2019, for U.S. Appl. No. 15/652,068, filed Jul. 17, 2017, 11 pages. |
Non-Final Office Action dated Feb. 24, 2020, for U.S. Appl. No. 15/572,757, filed Nov. 8, 2017, 6 pages. |
Notice of Allowance dated Apr. 28, 2010, for U.S. Appl. No. 10/901,019, filed Jul. 27, 2004, 7 pages. |
Notice of Allowance dated Aug. 16, 2018, for U.S. Appl. No. 15/265,781, filed Sep. 14, 2016, 7 pages. |
Notice of Allowance dated Aug. 4, 2009, for U.S. Appl. No. 10/901,555, filed Jul. 27, 2004, 7 pages. |
Notice of Allowance dated Dec. 19, 2017, for U.S. Appl. No. 14/626,826, filed Feb. 19, 2015, 8 pages. |
Notice of Allowance dated Dec. 6, 2010, for U.S. Appl. No. 12/132,375, filed Jun. 3, 2008, 9 pages. |
Notice of Allowance dated Feb. 24, 2010, for U.S. Appl. No. 10/656,797, filed Sep. 4, 2003, 8 pages. |
Notice of Allowance dated Jul. 26, 2011, for U.S. Appl. No. 11/894,530, filed Aug. 20, 2007, 10 pages. |
Notice of Allowance dated Jun. 11, 2012, for U.S. Appl. No. 10/741,130, filed Dec. 19, 2003, 9 pages. |
Notice of Allowance dated Jun. 15, 2016, for U.S. Appl. No. 14/156,347, filed Jan. 15, 2014, 7 pages. |
Notice of Allowance dated Jun. 22, 2018, for U.S. Appl. No. 15/265,781, filed Sep. 14, 2016, 8 pages. |
Notice of Allowance dated Mar. 17, 2014, for U.S. Appl. No. 12/366,553, filed Feb. 5, 2009, 8 pages. |
Notice of Allowance dated Mar. 2, 2015, for U.S. Appl. No. 12/187,331, filed Aug. 6, 2008, 5 pages. |
Notice of Allowance dated Nov. 17, 2010, for U.S. Appl. No. 11/232,190, filed Sep. 20, 2005, 11 pages. |
Notice of Allowance dated Nov. 8, 2017, for U.S. Appl. No. 13/820,447, filed Oct. 18, 2013, 8 pages. |
Notice of Allowance dated Oct. 29, 2015, for U.S. Appl. No. 10/901,554, filed Jul. 27, 2004, 8 pages. |
Notice of Allowance dated Sep. 25, 2013, for U.S. Appl. No. 12/132,161, filed Jun. 3, 2008, 12 pages. |
Notice of Allowance dated Sep. 16, 2019, for U.S. Appl. No. 15/652,068, filed Jul. 17, 2017, 8 pages. |
Notice of Allowance dated Feb. 24, 2020, for U.S. Appl. No. 15/955,564, filed Apr. 17, 2018, 9 pages. |
Notice of Allowance dated Dec. 23, 2020, for U.S. Appl. No. 15/572,757, filed Nov. 8, 2017, 8 pages. |
Shumay, S.J. et al. (Dec. 1988). “A ‘Designer’ Annuloplasty Ring for Patients with Massive Mitral Annular Dilatation,” Ann. Thorac. Surg. 46(6):695-696. |
Supplementary European Search Report dated Nov. 10, 2008, for EP Application No. 04 78 2847, filed on Sep. 1, 2004, 2 pages. |
U.S. Appl. No. 11/875,774, filed Oct. 19, 2007, by Serina et al. |
Written Opinion dated Nov. 17, 2016 in PCT Application No. PCT/US2016/032220 filed May 12, 2016. 4 pages. |
Written Opinion of the International Searching Authority dated Apr. 2, 2007, for PCT Application No. PCT/US2006/043597, filed Nov. 8, 2006, 7 pages. |
Written Opinion of the International Searching Authority dated Dec. 19, 2006, for PCT Application No. PCT/US2006/031190, filed Aug. 10, 2006, 6 pages. |
Written Opinion of the International Searching Authority dated Mar. 7, 2007, for PCT Patent Application No. PCT/US2004/028431, filed on Sep. 1, 2004, 4 pages. |
Written Opinion of the International Searching Authority dated Sep. 19, 2009, for PCT Patent Application No. PCT/US2009/033252, filed on Feb. 5, 2009, 7 pages. |
Number | Date | Country | |
---|---|---|---|
20210290902 A1 | Sep 2021 | US |
Number | Date | Country | |
---|---|---|---|
62160595 | May 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15572757 | US | |
Child | 17221321 | US |